{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:19:01Z","timestamp":1778991541243,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(Grants 81871387"],"award-info":[{"award-number":["(Grants 81871387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671733"],"award-info":[{"award-number":["81671733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871386)"],"award-info":[{"award-number":["81871386)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["(Grants 7202027)"],"award-info":[{"award-number":["(Grants 7202027)"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00259-023-06294-1","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T01:02:06Z","timestamp":1686790926000},"page":"3414-3424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Superiority of [68Ga]Ga-DOTA-FAPI-04 PET\/CT to [18F]FDG PET\/CT in the evaluation of thymic epithelial tumours"],"prefix":"10.1007","volume":"50","author":[{"given":"Xiuling","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-7550","authenticated-orcid":false,"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"6294_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jtho.2022.02.001","volume":"17","author":"DW Shin","year":"2022","unstructured":"Shin DW, Cho JH, Ha J, Jung KW. Trends in incidence and survival of patients with thymic epithelial tumor in a high-incidence Asian country: analysis of the Korean Central Cancer Registry 1999 to 2017. J Thorac Oncol. 2022;17:827\u201337. https:\/\/doi.org\/10.1016\/j.jtho.2022.02.001.","journal-title":"J Thorac Oncol"},{"key":"6294_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","volume":"17","author":"A Marx","year":"2022","unstructured":"Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022;17:200\u201313. https:\/\/doi.org\/10.1016\/j.jtho.2021.10.010.","journal-title":"J Thorac Oncol"},{"key":"6294_CR3","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1002\/cncr.23492","volume":"112","author":"AM Marchevsky","year":"2008","unstructured":"Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran C, Zakowski MF, et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer. 2008;112:2780\u20138. https:\/\/doi.org\/10.1002\/cncr.23492.","journal-title":"Cancer"},{"key":"6294_CR4","doi-asserted-by":"publisher","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","volume":"6","author":"FC Detterbeck","year":"2011","unstructured":"Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol. 2011;6:S1710\u20136. https:\/\/doi.org\/10.1097\/JTO.0b013e31821e8cff.","journal-title":"J Thorac Oncol"},{"key":"6294_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/sj.bjc.6603833","volume":"97","author":"HS Lee","year":"2007","unstructured":"Lee HS, Kim ST, Lee J, Choi YS, Han JH, Ahn YC, et al. A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management. Br J Cancer. 2007;97:22\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6603833.","journal-title":"Br J Cancer"},{"key":"6294_CR6","doi-asserted-by":"publisher","unstructured":"Expert Panel on Thoracic I, Ackman JB, Chung JH, Walker CM, Bang TJ, Carter BW, et al. ACR appropriateness criteria(R) imaging of mediastinal masses. J Am Coll Radiol. 2021;18:S37-S51. https:\/\/doi.org\/10.1016\/j.jacr.2021.01.007.","DOI":"10.1016\/j.jacr.2021.01.007"},{"key":"6294_CR7","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1097\/JTO.0b013e31821c4203","volume":"6","author":"EM Marom","year":"2011","unstructured":"Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, et al. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol. 2011;6:1274\u201381. https:\/\/doi.org\/10.1097\/JTO.0b013e31821c4203.","journal-title":"J Thorac Oncol"},{"key":"6294_CR8","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s00330-015-4031-6","volume":"26","author":"AM Priola","year":"2016","unstructured":"Priola AM, Priola SM, Giraudo MT, Gned D, Fornari A, Ferrero B, et al. Diffusion-weighted magnetic resonance imaging of thymoma: ability of the apparent diffusion coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival. Eur Radiol. 2016;26:2126\u201338. https:\/\/doi.org\/10.1007\/s00330-015-4031-6.","journal-title":"Eur Radiol"},{"key":"6294_CR9","first-page":"1628","volume":"47","author":"YM Sung","year":"2006","unstructured":"Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA. 18F-FDG PET\/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med. 2006;47:1628\u201334.","journal-title":"J Nucl Med"},{"key":"6294_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.lungcan.2011.02.018","volume":"74","author":"A Terzi","year":"2011","unstructured":"Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, et al. Usefulness of 18-F FDG PET\/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Lung Cancer. 2011;74:239\u201343. https:\/\/doi.org\/10.1016\/j.lungcan.2011.02.018.","journal-title":"Lung Cancer"},{"key":"6294_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/JTO.0b013e3182835549","volume":"8","author":"MF Benveniste","year":"2013","unstructured":"Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, et al. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. J Thorac Oncol. 2013;8:502\u201310. https:\/\/doi.org\/10.1097\/JTO.0b013e3182835549.","journal-title":"J Thorac Oncol"},{"key":"6294_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11748-020-01439-7","volume":"69","author":"T Ito","year":"2021","unstructured":"Ito T, Suzuki H, Sakairi Y, Wada H, Nakajima T, Yoshino I. 18F-FDG-PET\/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2021;69:274\u201381. https:\/\/doi.org\/10.1007\/s11748-020-01439-7.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"6294_CR13","doi-asserted-by":"publisher","unstructured":"Tatematsu T, Okuda K, Saito Y, Oda R, Sakane T, Yokota K, et al. The usefulness of fluorodeoxyglucose-positron emission tomography as a preoperative diagnostic tool for thymic epithelial tumors. Gland Surg. 2021;10:690\u20136. https:\/\/doi.org\/10.21037\/gs-20-718.","DOI":"10.21037\/gs-20-718"},{"key":"6294_CR14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00330-021-08230-z","volume":"32","author":"S Han","year":"2022","unstructured":"Han S, Kim YI, Oh JS, Seo SY, Park MJ, Lee GD, et al. Diagnostic and prognostic values of 2-[18F]FDG PET\/CT in resectable thymic epithelial tumour. Eur Radiol. 2022;32:1173\u201383. https:\/\/doi.org\/10.1007\/s00330-021-08230-z.","journal-title":"Eur Radiol"},{"key":"6294_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18:99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1.","journal-title":"Nat Rev Drug Discov"},{"key":"6294_CR16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nucl Med"},{"key":"6294_CR17","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00259-022-05818-5","volume":"49","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang S, Xu X, Meng X, Zhang H, Zhang A, et al. Higher accuracy of [68Ga]Ga-DOTA-FAPI-04 PET\/CT comparing with 2-[18F]FDG PET\/CT in clinical staging of NSCLC. Eur J Nucl Med Mol Imaging. 2022;49:2983\u201393. https:\/\/doi.org\/10.1007\/s00259-022-05818-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6294_CR18","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47:1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6294_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"key":"6294_CR20","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.Ccr-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13:1736\u201341. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-1746.","journal-title":"Clin Cancer Res"},{"key":"6294_CR21","doi-asserted-by":"publisher","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (Oxford, England:1990). 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"6294_CR22","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/jto.0000000000000291","volume":"9","author":"K Kondo","year":"2014","unstructured":"Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, et al. The IASLC\/ITMIG thymic epithelial tumors staging project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S81\u20137. https:\/\/doi.org\/10.1097\/jto.0000000000000291.","journal-title":"J Thorac Oncol"},{"key":"6294_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1213\/ane.0000000000005593","volume":"133","author":"EO Bayman","year":"2021","unstructured":"Bayman EO, Dexter F. Multicollinearity in logistic regression models. Anesth Analg. 2021;133:362\u20135. https:\/\/doi.org\/10.1213\/ane.0000000000005593.","journal-title":"Anesth Analg"},{"key":"6294_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/(sici)1097-0258(19970715)16:13<1529::aid-sim565>3.0.co;2-h","volume":"16","author":"NA Obuchowski","year":"1997","unstructured":"Obuchowski NA, McClish DK. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med. 1997;16:1529\u201342. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19970715)16:13%3c1529::aid-sim565%3e3.0.co;2-h.","journal-title":"Stat Med"},{"key":"6294_CR25","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Thymomas and thymic carcinomas version 1.2023.\u00a0https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thymic.pdf. Published December 15, 2022. Accessed 17 April 2023."},{"key":"6294_CR26","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1093\/ejcts\/ezt263","volume":"44","author":"H Toba","year":"2013","unstructured":"Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, et al. 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1alpha, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Eur J Cardiothorac Surg. 2013;44:e105\u201312. https:\/\/doi.org\/10.1093\/ejcts\/ezt263.","journal-title":"Eur J Cardiothorac Surg"},{"key":"6294_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejrad.2010.08.010","volume":"81","author":"M Nakajo","year":"2012","unstructured":"Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, et al. 18FDG PET for grading malignancy in thymic epithelial tumors: significant differences in 18FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Eur J Radiol. 2012;81:146\u201351. https:\/\/doi.org\/10.1016\/j.ejrad.2010.08.010.","journal-title":"Eur J Radiol"},{"key":"6294_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18:70. https:\/\/doi.org\/10.1186\/s12943-019-0994-2.","journal-title":"Mol Cancer"},{"key":"6294_CR29","doi-asserted-by":"publisher","unstructured":"Wu Z, Xue S, Zheng B, Ye R, Xu G, Zhang S, et al. Expression and significance of c-kit and epithelial-mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs). J Thorac Dis. 2019;11:4602\u201312. https:\/\/doi.org\/10.21037\/jtd.2019.10.56.","DOI":"10.21037\/jtd.2019.10.56"},{"key":"6294_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/1759-7714.13755","volume":"12","author":"K Minami","year":"2021","unstructured":"Minami K, Jimbo N, Tanaka Y, Uchida T, Okamoto T, Shimizu N, et al. Fibrous bands associated with higher Masaoka stage and poor recurrence-free survival in patients with thymoma. Thorac Cancer. 2021;12:349\u201356. https:\/\/doi.org\/10.1111\/1759-7714.13755.","journal-title":"Thorac Cancer"},{"key":"6294_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2967\/jnumed.119.237446","volume":"61","author":"JR Barrio","year":"2020","unstructured":"Barrio JR, Huang SC, Satyamurthy N, Scafoglio CS, Yu AS, Alavi A, et al. Does 2-FDG PET accurately reflect quantitative in vivo glucose utilization? J Nucl Med. 2020;61:931\u20137. https:\/\/doi.org\/10.2967\/jnumed.119.237446.","journal-title":"J Nucl Med"},{"key":"6294_CR32","doi-asserted-by":"publisher","unstructured":"Meyer HJ, Wienke A, Surov A. Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. PLoS ONE. 2019;14:e0217781. https:\/\/doi.org\/10.1371\/journal.pone.0217781.","DOI":"10.1371\/journal.pone.0217781"},{"key":"6294_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, et al. Comparison of (68)Ga-FAPI and (18)F-FDG PET\/CT in the evaluation of advanced lung cancer. Radiology. 2022;303:191\u20139. https:\/\/doi.org\/10.1148\/radiol.211424.","journal-title":"Radiology"},{"key":"6294_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4942","volume":"243","author":"A Capobianco","year":"2017","unstructured":"Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243:137\u201347. https:\/\/doi.org\/10.1002\/path.4942.","journal-title":"J Pathol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06294-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06294-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06294-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T07:03:23Z","timestamp":1695971003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06294-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6294"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06294-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Clinical Research Ethics Committee of Peking University Cancer Hospital (2019KT95). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}